6550
北極星藥業-KY
-0.23 (-2.25%)9.972,215成交張數–本益比1.97股價淨值比0.00%殖利率2026-09-11資料日期
ROE 與 ROA
近四季合計;近十年
每股淨值
元
負債比率
負債總額 / 資產總額
現金流量
單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)
| 季度 | 資產總額(億) | 母公司權益(億) | 負債比率 | 流動比率 | 每股淨值 | ROE(近四季) | ROA(近四季) | 營業現金流(億) | 自由現金流(億) |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 74 | 45 | 38.5% | 5.12 | 5.07 | -81.6% | -48.4% | -3.9 | -3.9 |
| 2026Q1 | 76 | 48 | 37.1% | 4.80 | 5.58 | -69.7% | -45.9% | -5.2 | -6.4 |
| 2025Q4 | 82 | 53 | 35.2% | 5.15 | 6.16 | -65.5% | -45.5% | -5.9 | -7.6 |
| 2025Q3 | 82 | 42 | 48.8% | 1.30 | 5.44 | -60.2% | -37.5% | -6.0 | -8.8 |
| 2025Q2 | 82 | 47 | 41.9% | 2.38 | 6.09 | -53.9% | -36.1% | -5.9 | -7.7 |
| 2025Q1 | 90 | 61 | 31.1% | 5.93 | 7.97 | -41.4% | -31.1% | -6.1 | -7.8 |
| 2024Q4 | 91 | 67 | 25.5% | 7.09 | 8.69 | -35.6% | -27.5% | -6.2 | -9.3 |
| 2024Q3 | 83 | 61 | 25.7% | 6.67 | 8.15 | -30.9% | -24.9% | -4.9 | -7.7 |
| 2024Q2 | 91 | 69 | 23.2% | 9.86 | 9.22 | -25.2% | -20.6% | -5.2 | -12.3 |
| 2024Q1 | 89 | 73 | 16.5% | 12.78 | 9.78 | -21.6% | -18.4% | -4.0 | -7.6 |
| 2023Q4 | 91 | 74 | 16.1% | 5.32 | 9.90 | -19.7% | -17.2% | -4.2 | -5.8 |
| 2023Q3 | 94 | 82 | 12.3% | 8.74 | 10.97 | -15.3% | -13.8% | -3.9 | -4.4 |
| 2023Q2 | 95 | 83 | 11.9% | 9.02 | 11.13 | – | – | -2.3 | -3.1 |
| 2023Q1 | 95 | 84 | 11.8% | 9.40 | 11.34 | – | – | -2.2 | -2.6 |
| 2022Q4 | 92 | 87 | 5.9% | 30.06 | 11.69 | – | – | -3.9 | -4.0 |
| 2022Q3 | 98 | 92 | 6.3% | 24.70 | 12.36 | – | – | – | – |